Key protein in chikungunya virus replication identified
Researchers have found that the FHL1 protein plays a key role in chikungunya virus replication and pathogenesis.
List view / Grid view
Researchers have found that the FHL1 protein plays a key role in chikungunya virus replication and pathogenesis.
A new method to reactivate 'tumour suppressor' genes switched off by cancer cells could lead to new targeted biotherapies for cancer.
A study has revealed that the mitoNEET protein controls a metabolic and functional gateway on mitochondria, which could provide a drug target for cancer.
The memory of mice with Alzheimer's greatly improved after they were injected with two newly discovered short peptides.
Currently, there is no licensed treatment to slow or stop the progression of Parkinson’s disease. However, a team at Sheffield University in the UK are currently working to identify compounds that target the dopaminergic brain cells affected by the disease. Nikki Withers speaks to Dr Heather Mortiboys to hear how…
Chronic inflammatory processes in ageing brains lead to lymphoma cells that have entered the brain tissue being retained.
We are on the precipice of realising the true potential of genomics studies. Following completion of the Human Genome Project six years ago, huge strides have been made in understanding how the genome works, shedding light on disease pathogenesis and forging therapeutic efforts. In this article, Pushpanathan Muthuirulan explains how…
Having worked in antibody research for over 20 years, Gary McLean has seen how the industry has progressed and understands the potential that antibodies have in the future of medicine. Nikki Withers hears how the focus has shifted from discovery to genetic sequence manipulation and how this can be applied…
Protein therapeutics are a major class of biopharmaceuticals and monoclonal antibodies (mAbs) rule this domain. In this article, Dr Nancy Lopez-Anton outlines the key technologies employed in this important therapeutic discovery area; how they have evolved and what obstacles must be navigated to ensure future success.
New research findings suggest that gut microbiota may regulate lupus flares in pregnant women, presenting a therapeutic target.
Scientists have discovered a molecular pathway that contributes to PAH development, which may lead to a new drug target for the disease.
The UK Biobank, the world’s largest genetics project, will sequence 500,000 genetic samples, which will be available to researchers everywhere.
Using both computational models and stem cell-based experiments, researchers have identified a gene regulator of schizophrenia.
A study on how Polycombs regulate cellular identity could lead to alternative treatments for patients with drug-resistant cancer.
Using mice models in late adolescence, researchers have successfully treated schizophrenia which could help develop therapies for the condition.